MedicQuant, a spin-off from Aarhus University established in 2019, is rooted in cutting-edge biosensor research conducted at the Gothelf Lab at iNANO. Our mission is to redefine the standard for small molecule diagnostics, with a particular emphasis on enhancing stroke patient management. The core of this project is the innovation and automation of our production platform to boost performance and ensure long-term stability.